Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vyant Bio Inc (VYNT)

Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,228
  • Shares Outstanding, K 6,329
  • Annual Sales, $ 670 K
  • Annual Income, $ -22,690 K
  • 60-Month Beta 1.68
  • Price/Sales 1.71
  • Price/Cash Flow N/A
  • Price/Book 0.27
Trade VYNT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.62
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/02/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1591 +21.94%
on 12/11/23
0.2000 -3.00%
on 12/29/23
+0.0165 (+9.30%)
since 11/29/23
3-Month
0.1500 +29.33%
on 10/09/23
0.2100 -7.62%
on 11/02/23
+0.0240 (+14.12%)
since 09/29/23
52-Week
0.1410 +37.59%
on 09/25/23
1.5800 -87.72%
on 01/05/23
-0.5060 (-72.29%)
since 12/29/22

Most Recent Stories

More News
Pre-Market Brief: Stocks Mixed After FOMC Minutes Temper Policy Pivot Hopes

March S&P 500 futures (ESH23) are trending down -0.07% this morning after three major U.S. benchmark indices finished higher in volatile trading on Wednesday as investors digested the release of the Federal...

ESH23 : 3,957.05s (-0.09%)
NXT.LN : 8,940.728 (+0.01%)
VYNT : 0.1940 (+7.78%)
GERN : 4.60 (-1.50%)
AMZN : 183.13 (-0.34%)
SLP : 39.54 (-4.40%)
LAZR : 1.6700 (-8.49%)
TMUS : 182.05 (-0.13%)
Vyant Bio Announces Investor Conference Call and Webcast for the Second Quarter and First Half of 2022

CHERRY HILL, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services

CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights

Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights  ●Progress in the discovery of small molecule therapeutics to...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022

CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference

CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights

Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to...

VYNT : 0.1940 (+7.78%)
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease

Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an...

VYNT : 0.1940 (+7.78%)
Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021

CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)
Vyant Bio Issues Letter to Shareholders

Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company...

VYNT : 0.1940 (+7.78%)

Business Summary

VYANT BIO INC. operates through wholly-owned subsidiaries, StemoniX and vivoPharm. StemoniX is empowering the discovery of new medicines through the convergence of novel human biology and software technologies. vivoPharm offers proprietary preclinical test systems supporting clinical diagnostic offerings...

See More

Key Turning Points

3rd Resistance Point 0.2293
2nd Resistance Point 0.2147
1st Resistance Point 0.2043
Last Price 0.1940
1st Support Level 0.1793
2nd Support Level 0.1647
3rd Support Level 0.1543

See More

52-Week High 1.5800
Fibonacci 61.8% 1.0303
Fibonacci 50% 0.8605
Fibonacci 38.2% 0.6907
Last Price 0.1940
52-Week Low 0.1410

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar